WHO ICTRP trial

Phase I/II Study of DS-5141b

JPRN-jRCT2080223018 · Japan Primary Registries Network (JPRN) · Not Recruiting

Key facts

Trial ID JPRN-jRCT2080223018
Public title Phase I/II Study of DS-5141b
Scientific title Phase I/II Study of DS-5141b: Open-label study of DS-5141b in patients with Duchenne muscular dystrophy
Primary sponsor DAIICHISANKYO Co.,Ltd.
Secondary sponsors Orphan Disease Treatment Institute Co., Ltd.
Registry Japan Primary Registries Network (JPRN)
Recruitment status Not Recruiting
Study type Interventional
Phase 1-2
Countries Japan
Conditions Duchenne muscular dystrophy
Interventions investigational material(s) Generic name etc : DS-5141b INN of investigational material : - Therapeutic category code : 49- Other agents affecting cellular function Dosage and Administration for Investigational material : subcutaneous…
Registration date Nov 18, 2015
Target size 6
Secondary IDs NCT02667483;JapicCTI-153072
Registry page jrct.niph.go.jp

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations